U.S. flag

An official website of the United States government

NM_005121.3(MED13):c.4852G>C (p.Asp1618His) AND Intellectual developmental disorder 61

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003447772.1

Allele description [Variation Report for NM_005121.3(MED13):c.4852G>C (p.Asp1618His)]

NM_005121.3(MED13):c.4852G>C (p.Asp1618His)

Gene:
MED13:mediator complex subunit 13 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q23.2
Genomic location:
Preferred name:
NM_005121.3(MED13):c.4852G>C (p.Asp1618His)
HGVS:
  • NC_000017.11:g.61962964C>G
  • NG_046948.1:g.107348G>C
  • NM_005121.3:c.4852G>CMANE SELECT
  • NP_005112.2:p.Asp1618His
  • NC_000017.10:g.60040325C>G
Protein change:
D1618H
Molecular consequence:
  • NM_005121.3:c.4852G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Intellectual developmental disorder 61
Synonyms:
MENTAL RETARDATION, AUTOSOMAL DOMINANT 61; INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61
Identifiers:
MONDO: MONDO:0032485; MedGen: C5231400; OMIM: 618009

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004175512Genetics and Molecular Pathology, SA Pathology

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 11, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genetics and Molecular Pathology, SA Pathology, SCV004175512.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The MED13 c.4852G>C variant is classified as VUS (PP3) The MED13 c.4852G>C variant is a single nucleotide change in exon 21/30 of the MED13 gene, which is predicted to change the amino acid aspartic acid at position 1618 in the protein to histidine. Computational predictions support a deleterious effect on the gene or gene product (PP3). The variant has been reported in dbSNP (rs200976941). It has not been reported in ClinVar or HGMD.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 17, 2023